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The anticancer activity of cisplatin is triggered by its formation of intrastrand adducts involving adjacent G
residues of DNA. To obtain information on the diﬀerent conformers that can be formed, carrier ligands
such as 2,2’-bipiperidine, which provide large steric bulk near the platinum coordination plane and
decrease the dynamic motion about the Pt–N7 bonds, were introduced (“retro-modelling” approach). In
the present study we investigate the eﬀect of cis-1,4-diaminocyclohexane (cis-1,4-DACH) on the for-
mation, stability, and stereochemistry of (cis-1,4-DACH)Pt(ss-oligo) adducts (ss-oligo = d(GpG) with
3’- and/or 5’-substituents). Interesting features of this ligand, absent in previous retro-modelling studies,
include the large bite angle (expected to impede the ease of interconversion between possible confor-
mers), the presence of two protons on each nitrogen (a characteristic associated with antitumor activity),
and the absence of chiral centres. The use of cis-1,4-DACH has made it possible to detect diﬀerent con-
formers in a system containing a primary diamine carrier ligand associated with anticancer activity and to
conﬁrm the previous hypothesis that the coexistence of diﬀerent conformers established in studies of
retro models having relatively bulky ligands is not an artefact resulting from carrier-ligand bulk. Moreover,
the data for the (cis-1,4-DACH)Pt(d(GpG)) and (cis-1,4-DACH)Pt(d(GGTTT)) adducts indicate that at a
temperature close to the physiological one (40 °C) HH1 and ΔHT1 conformers are present in comparable
amounts. In contrast, at low temperature (close to 0 °C) the equilibrium shifts dramatically toward the
more stable HH1 conformer (for the (cis-1,4-DACH)Pt(d(TGGT)) adduct the HH1 conformer is always
dominant, even at high temperature). Notably, (cis-1,4-DACH)PtCl2 (Kiteplatin) has been recently reinves-
tigated and found to be particularly active against colorectal cancer (including oxaliplatin-resistant
phenotypes).
Introduction
The anticancer activity of cisplatin, cis-[PtCl2(NH3)2], the proto-
type of platinum-based anticancer-drugs, is triggered by the
formation of intrastrand adducts involving Pt binding to the
N7 of two adjacent G residues of DNA.1–3 The two cross-linked
guanine bases adopt primarily a head-to-head (HH) arrange-
ment (Fig. 1), with both G residues maintaining the anti con-
formation typical of B-DNA (HH1 in Fig. 1).2,4–10 In contrast, in
interstrand cross-links, the guanine bases from the two
strands adopt a head-to-tail (HT) arrangement.11–14 Such inter-
strand cross-links could also contribute to the anticancer
activity.15,16
All evidence indicates that the HH1 conformer is clearly
dominant in cisplatin-(∼GpG∼) intrastrand adducts in which a
platinated strand is in a DNA duplex.11,17–26 However, in the
simple cis-(NH3)2Pt(d(GpG)) model and in cis-(NH3)2Pt(ss-
oligo) models (oligo = oligodeoxyribonucleotide, ss = single
strand), the dynamic nature of these adducts complicates the
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NMR spectroscopic analysis. In the limiting case in which
rotation about the Pt–N7 bonds is fast on the NMR time scale,
the informative potential of the NMR technique cannot be
realized.4–6,27–44 Watson–Crick base pairing reduces confor-
mational dynamics in duplexes.17–26
In cases in which the intrastrand cross-link clearly has an
HH1 conformation, such as in cis-A2Pt(d-oligo) adducts
(d-oligo = duplexed oligodeoxyribonucleotides; A2 = two mono-
dentate or one bidentate N donor carrier ligand), the H8
signals of the two Gs are not well separated (δ ∼ 0.3 ppm), with
the 3′-G H8 upfield and the 5′-G H8 downfield. The 3′-G base
is canted, and the 3′-G H8 is positioned near the anisotropic
region of the 5′-G base.20,21,23,26,45 This is called right-handed
(R) canting because the straight line connecting the N7 of the
two coordinated guanines and the arrow mimicking the 3′-G
base can be represented by the index and thumb of the right
hand (Fig. 1). In cis-A2Pt(ss-oligo) adducts in which A2 is a
non-bulky ligand, the 5′-G H8 is positioned by 5′-G base
canting near the anisotropic 3′-G base. Such left-handed (L)
canted adducts (the straight line connecting the N7 of the two
coordinated guanines and the arrow mimicking the 5′-G base
are represented by the index and thumb of the left hand,
Fig. 1) have an upfield 5′-G H8 signal and a very downfield 3′-G
H8 signal. This signal separation is clear and large when the
cross-link is not at the 5′ end of the ss-oligo,5,6,27,31,33,34,43
i.e., when there is at least one nucleotide residue in the posi-
tion 5′ to the 5′-G in the cross-link.
To obtain information on the diﬀerent conformers, many
investigators have studied adducts of short ss-oligos by
employing the Marzilli and Natile “retro-modelling”
approach.17,46–53 These studies used carrier ligands (A2) that
provide large steric bulk in or near the platinum coordination
plane in order to decrease the dynamic motion about the Pt–
N7 bonds, thus allowing multiple conformers to coexist and to
interconvert slowly on the NMR time scale, even if the adducts
involved ss-oligos.11,17,46–48,54–57 Studies of retro models have
shown that all major conformers (namely, HH1, HH2, ΔHT1,
and ΛHT2, Fig. 1) are possible.17,46,58–63 These major confor-
mers, in turn, can have several sub-forms diﬀering in back-
bone conformation and base canting (R or L).
One of the most successful carrier ligands used in retro
models has been 2,2′-bipiperidine (Bip) (Chart 1) in two
diﬀerent configurations (S,R,R,S or R,S,S,R configurations at
the N, C, C, and N chelate ring atoms).17,46–48,53,55,59,64 The
stereochemistry of the Bip carrier ligand influences both the
conformer distribution and the cross-link handedness. For
example, ((R,S,S,R)-Bip)Pt(d(GpG)) was shown to have two
abundant right-handed conformers (HH1 R, HH2 R), and
((S,R,R,S)-Bip)Pt(d(GpG)) was shown to have two abundant left-
handed conformers (HH1 L, ΔHT1 L).17,46,59 In these confor-
mers at least one guanine base is oriented such that its O6 is
on the same side of the coordination plane as a Bip NH
proton; thus, a G O6-NH hydrogen bond could form. In each
case, the observed base canting direction of that G residue
permits such H-bonding. Another successful ligand in “retro-
model” studies was the N,N,N′,N′-tetramethyl-2,3-diamino-
butane ligand (Me4DAB), with S,S or R,R configurations at the
chelate ring atoms (Chart 1), and showing analogous
results.10,58
Our objective in the present study was to assess the pro-
perties of cis-1,4-diaminocyclohexane (cis-1,4-DACH) by deter-
mining the eﬀect of the carrier ligand on the formation,
stability, and stereochemistry of (cis-1,4-DACH)Pt(ss-oligo)
adducts. An interesting feature of this ligand is its ∼97° bite
angle,65 which is larger than that of cisplatin (∼90°; Chart 2)
Fig. 1 Possible conformers of cis-A2Pt(∼GpG∼) cross-links (A2 = two
amines or a bidentate diamine; (∼GpG∼) = adjacent G residues in oligo-
deoxyribonucleotides). The arrows represent the G bases, and the phos-
phodiester backbone (placed in the front) is represented by a curved line
linking the two arrows. Interconversion between conformers is possible
via rotation about the Pt–G bonds. HT1 and HT2 diﬀer, respectively, for
the Δ and Λ handedness of the two straight lines, one perpendicular to
the coordination plane and passing through Pt and the other connecting
the O6 atoms of the two guanines. HH1 and HH2 diﬀer, respectively, for
the north or south orientations of the arrows representing the guanines,
having placed 5’-G on the left- and 3’-G on the right-hand side. Canting
handedness is deﬁned by two straight lines, one connecting the N7
atoms of the two coordinated guanines and the other overlapping the
arrow representing a given guanine.
Chart 1
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and of analogous compounds with ethylenediamine (en, 83°)66
or 1,2-DACH (83.2°, average value of three Pt complexes).67 The
large bite angle of cis-1,4-DACH complexes could also reduce
the (amine)NH2–Pt–N7(G) angles, thus possibly influencing
the distribution of conformers and likely diminishing the ease
of interconversion between possible conformers. Such an
impeded interconversion was reported for the (cis-1,4-DACH)Pt-
(5′-GMP)2 adduct (having two untethered guanine derivatives),
for which 1H NMR evidence for all three possible conformers
(HH, ΔHT, and ΛHT) was observed by lowering the tempera-
ture to −35 °C. (For such adducts with untethered guanine
bases, conformer designations lack the 1 and 2, which desig-
nate backbone direction, and the HH1 and HH2 conformers
shown in Fig. 1 become equivalent.)65 The equilibrium compo-
sition of the three conformers was 33% HH, 51% ΛHT, and
16% ΔHT. The high abundance of the ΛHT conformer arises
from “second-sphere communication” in which the 5′-phos-
phate of each 5′-GMP interacts with the guanine base NH
group of the cis-5′-GMP.10 Another key feature of the cis-1,4-
DACH ligand is that both donors are primary amines. This
characteristic, which was not explored in previous retro-model
studies, usually favours antitumour activity. Finally, the 1R,2R-
DACH ligand in the anticancer drug oxaliplatin ((1R,2R-DACH)-
Pt(oxalate), Chart 2) and amine ligands used in retro-model
studies have chiral centres, while cis-1,4-DACH has no chiral
centres and hence cannot influence the chirality of (cis-1,4-
DACH)Pt(DNA) adducts.
The cis-1,4-DACH carrier ligand was introduced into plati-
num-based drug research many years ago, as an alternative to
1R,2R-DACH in oxaliplatin, a third generation platinum drug
with a spectrum of activity not superimposable on that of cis-
platin.68 However, after some initial interest, cis-1,4-DACH was
set aside. More recently, [PtCl2(cis-1,4-DACH)] (Kiteplatin,
Chart 2) was extensively reinvestigated by some of us, and it
was found to have potential application against colorectal
cancer (including oxaliplatin-resistant phenotypes).65,69–73
In this work, (cis-1,4-DACH)Pt(d(GpG)), (cis-1,4-DACH)Pt-
(d(GGTTT)), and (cis-1,4-DACH)Pt(d(TGGT)) adducts were
investigated by employing 1H and 31P NMR spectroscopy com-
plemented with a combination of molecular mechanics and
semi-empirical quantum-chemical calculations. It should be
noted that the triplet GGT present in the latter two adducts is
also part of the repetitive sequence in single-strand telomeres,
which could also be potential targets for platinum
drugs.63,74–76
Experimental section
Materials and methods
NMR spectra were recorded on Bruker instruments (Avance
DPX 300 MHz, Avance DPX 400 MHz, Avance II 600 MHz, and
Avance III 700 MHz) equipped with variable-temperature units.
Standard Bruker pulse sequences were employed for the NMR
experiments, using gradient selected versions when necessary.
In particular, 2D NMR spectra (NOESY, COSY, TOCSY) with
water suppression were obtained by using the standard Bruker
sequence with presaturation or excitation sculpting.77
DNO3 and NaOD solutions (0.1 M in D2O) were used to
adjust the pH of the D2O solutions.
1H NMR experiments at
diﬀerent temperatures were referenced to the residual HOD
peak (1H). 1H-decoupled 31P NMR spectra were recorded using
trimethyl phosphate (TMP) in D2O as an external reference
(+2.10 ppm with respect to H3PO4, 85% m/m, placed at
0 ppm). The spectra recorded at −10 °C, on samples dissolved
in D2O–CD3OD (70/30, v/v), were referenced to the internal
residual peak of CD3OD (
1H) or external TMP (31P) dissolved in
the same mixture.
Deoxyguanyl(3′–5′)deoxyguanosine (d(GpG)) was purchased
from Sigma and was, in part, also provided by Prof. Jan
Reedijk (Leiden University, The Netherlands). d(GGTTT) and
d(TGGT) were synthesized at the Emory Microchemistry Facil-
ity (Atlanta, GA) and purified by FPLC, using deionized water
and 2 M NaCl water solution as eluents. Oligonucleotide con-
centrations were determined by using the following ε260 at
25 °C: 46 300 M−1 cm−1 for d(GGTTT) and 37 600 M−1 cm−1 for
d(TGGT).78
The cis-1,4-DACH carrier ligand and the [PtCl2(cis-1,4-
DACH)] complex were synthesized according to previously
described procedures.65,79–81 As is commonly done, we used
an activated form of the platinum dichlorido drug, [Pt(OSO3)-
(OH2)(cis-1,4-DACH)], to produce the reactive diaqua species
after equilibration in water. [Pt(OSO3)(OH2)(cis-1,4-DACH)] was
prepared from [PtCl2(cis-1,4-DACH)] (60 mg, 0.16 mmol), sus-
pended in water (15 mL), and treated with Ag2SO4 (49.9 mg,
0.16 mmol). After stirring for 24 h at room temperature, the
suspension was filtered through Celite to remove AgCl and the
solvent evaporated to dryness under reduced pressure. The
white residue was the desired product (yield, 56.9 mg,
0.13 mmol, 81%). Anal. calculated for [Pt(OSO3)(OH2)(cis-1,4-
DACH)]·H2O (C6H18N2O6SPt): C, 16.33; H, 4.11; N, 6.35%.
Found: C, 16.50; H, 4.04; N, 6.33%.
Preparation of samples for NMR investigation
(cis-1,4-DACH)Pt(d(GpG)) was prepared from [Pt(OSO3)(OH2)-
(cis-1,4-DACH)] (1.2 mg, 0.0028 mmol) dissolved in D2O
(0.55 mL), left equilibrating at room temperature for 4 days
and then treated with d(GpG) (1.91 mg, 0.031 mmol;
Chart 2
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Pt : d(GpG) ratio of 1 : 1.1). The pH of the solution was adjusted
to ∼3 with DNO3 and the sample was kept at 5 °C. The pro-
gress of the reaction was monitored by 1H NMR spectroscopy,
and the disappearance of the G H8 signals of free d(GpG) indi-
cated that the reaction was complete.
(cis-1,4-DACH)Pt(d(GGTTT)) was prepared similarly to the
previous adduct from [Pt(OSO3)(OH2)(cis-1,4-DACH)] (1.17 mg,
0.0027 mmol), dissolved in D2O (0.690 mL), and, after equili-
bration for 4 days at room temperature, treated with d(GGTTT)
(4.1 mg, 0.0027 mmol; 1 : 1.1 Pt : d(GGTTT) ratio). The reaction
progress (room temperature) was monitored by 1H NMR spec-
troscopy using the G H8 and the T H6 signals of free
d(GGTTT) as indicators; the pH was always ∼4.
(cis-1,4-DACH)Pt(d(TGGT)) was also prepared in a similar
way from [Pt(OSO3)(OH2)(cis-1,4-DACH)] (1.23 mg,
0.0029 mmol) dissolved in D2O (0.690 mL), left to equilibrate
at room temperature for 4 days, and then treated with d(TGGT)
(3.49 mg, 0.0029 mmol; 1 : 1.1 Pt : d(TGGT) ratio). The reaction
progress (room temperature) was monitored by 1H NMR
spectroscopy by using the G H8 and the T H6 signals of free
d(TGGT) as indicators; the pH was always ∼4.
Calculations
A DNA adduct was constructed from PDB entry 1PGC through
truncation to two coordinated guanines plus the backbone,
and 1,2-DACH was converted into its 1,4 isomer manually,
retaining the position of the Pt and N atoms and adapting
cyclohexane into a boat-like conformation. Semi-empirical cal-
culations employed MOPAC with the PM6-DH2 method.82–84
Conformational freedom was explored by stochastic confor-
mational searching of all rotatable bonds in the d(GpG)
adduct using Deeth’s ligand field molecular mechanics
(LFMM) approach85 with previously reported parameters for
Pt(II)86,87 and with AMBER99 parameters for all other atoms88
and incorporating the Born model of aqueous solvation as
implemented in the DommiMOE89 extension to MOE.90
Results and discussion
Reaction with d(GpG)
A solution of the activated form of Kiteplatin, [Pt(OD2)2(cis-1,4-
DACH)]2+, and d(GpG) (1 : 1.1 molar ratio, 5 mM concentration
in D2O) at 5 °C and pH ∼ 3, prepared as above, was monitored
over time by 1H NMR spectroscopy (Fig. S1 in the ESI†).
Within a few days, the H8 signals of free d(GpG) (8.14 and
7.95 ppm for 3′-G and 5′-G, respectively) completely dis-
appeared, accompanied by the appearance of new, very broad
downfield-shifted H8 signals; this shift is consistent with for-
mation of (cis-1,4-DACH)Pt(d(GpG)) adducts. The G H1′
signals, which in free d(GpG) fall at 6.22 (3′-G) and 6.07 ppm
(5′-G), merged into a broad feature centred at 6.22 ppm upon
platination (Fig. S1†). The methynic and methylenic signals of
cis-1,4-DACH (respectively at 3.23 and 1.77 ppm in
[Pt(OD2)2(cis-1,4-DACH)]
2+) shifted downfield (to 3.40 and
1.89 ppm) upon reaction with d(GpG).
Temperature eﬀect. The broadness of the H8 signals indi-
cates that more conformers of the (cis-1,4-DACH)Pt(d(GpG))
adduct are present in D2O solution at 25 °C and that the con-
formers interconvert at a rate which is comparable to the NMR
time scale. A previous study showed that, by lowering the
temperature to −35 °C (solvent D2O–CD3OD, 2 : 1, v/v), it was
possible to identify diﬀerent conformers of the (cis-1,4-DACH)-
Pt(5′-GMP)2 adduct with untethered guanines.
65 Therefore, in
the present study we used a (cis-1,4-DACH)Pt(d(GpG)) sample
in D2O–CD3OD (2 : 1, v/v) to record NMR spectra at diﬀerent
temperatures (Fig. 2). As the temperature was raised, the broad
H8 signals in the 8.40–8.00 ppm region became sharper, and
at 55 °C the sample showed two major, rather sharp, H8
signals at 8.41 and 8.18 ppm, but there were still some broad
H8 signals, indicating that in addition to the major (cis-1,4-
DACH)Pt(d(GpG)) monomeric adduct, other species (possibly
platinum oligomers) were also present. Upon cooling to 25 °C,
the NMR sample had the same spectrum as before heating.
This reversible, temperature-dependent spectral change con-
firms that at room temperature the major component of the
sample is an adduct consisting of two or more conformers that
interconvert at a rate comparable to the NMR time scale.
Lowering the temperature of the NMR sample caused de-
coalescence of the broad H8 NMR signal observed at 25 °C
and, at the lowest temperature reached in the experiment
(−10 °C), two sharp H8 signals of equal intensity (at 8.94 and
8.46 ppm, Fig. 2) were observed, together with a more
shielded, very broad, H8 feature. Warming the NMR sample
Fig. 2 1H NMR (600 MHz) spectra in the region of H8 and H1’ reson-
ances for the (cis-1,4-DACH)Pt(d(GpG)) adduct in D2O–CD3OD (2 : 1,
v/v) at diﬀerent temperatures.
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back to room temperature restored the initial spectrum, con-
firming the presence of a dynamic equilibrium.
In order to assign the two sharp H8 peaks of equal intensity
detected at −10 °C to the corresponding conformer of (cis-1,4-
DACH)Pt(d(GpG)), we used a combination of 1D and 2D NMR
methods (NOESY, DQF-COSY, TOCSY, [1H,13C] HSQC, and
31P NMR). The 2D NOESY spectrum at −10 °C (Fig. 3) showed
an NOE cross-peak between the two sharp H8 signals (8.94
and 8.46 ppm). An H8–H8 cross-peak is indicative of an HH
conformer.10,11,24 The more upfield H8 signal (8.46 ppm)
showed two strong NOE cross-peaks to signals at 2.45 and
2.78 ppm. An NOE cross-peak was also observed between the
2.45 and 2.78 ppm signals. Moreover, both signals showed a
cross-peak to a signal at 6.08 ppm. The latter signal at
6.08 ppm had another NOE cross-peak to a signal at 4.08 ppm.
The H8 signal at 8.46 ppm also showed a strong NOE cross-
peak to a signal at 5.00 ppm. All these data, along with TOCSY
data, allowed us to assign the signals at 6.08, 2.45, 2.78, 5.00,
and 4.08 ppm to H1′, H2′, H2″, H3′, and H4′ sugar protons,
respectively (Table 1). The strong H8–H3′ NOE cross-peak indi-
cates an N-sugar pucker,46,91,92 a characteristic of a 5′-G
residue.46 Strong H8–H2′ and H8–H2″ NOE cross-peaks and an
almost undetectable H8–H1′ NOE cross-peak are all consistent
with the 5′-G residue having an anti conformation.59
The more downfield H8 signal (8.94 ppm) showed strong
NOE cross-peaks to signals at 2.45 and 2.57 ppm. The latter
two signals are connected by an NOE cross-peak. In addition,
both signals at 2.45 and 2.57 ppm have comparably intense
NOE cross-peaks to a signal at 6.26 ppm. An additional NOE
cross-peak is observed between signals at 6.26 and 4.16 ppm.
The latter has a cross-peak with a signal at 4.64 ppm. These
observations, along with TOCSY data, allow assignment of the
signals at 6.26, 2.45, 2.57, 4.64, and 4.16 ppm to the H1′, H2′,
H2″, H3′, and H4′ sugar protons, respectively (Table 1). The
absence of a significant H8–H3′ NOE cross-peak suggests that
the sugar of this residue retains the S pucker, a characteristic
of a 3′-G residue;91 thus, the downfield H8 signal belongs to
the 3′-G residue. The strong intranucleotide 3′-G H8–H2′/H2″
NOE cross-peaks and the weak 3′-G H8–H1′ NOE cross-peak
indicate that the 3′-G residue has anti conformation.91 The
combination of two anti G residues and downfield 3′-G H8 and
upfield 5′-G H8 signals is a clear indication of left-hand
canting of the 5′-G residue, a common feature of cis-A2Pt(ss-
oligo) adducts.
For the compound with untethered nucleotides, (cis-1,4-
DACH)Pt(5′-GMP)2, as mentioned above, the HT conformation
is favoured over HH.65 Conversely, the overall data obtained at
−10 °C confirm that, at this temperature, the more favoured
conformation of the (cis-1,4-DACH)Pt(d(GpG)) adduct is HH1.
Undoubtedly, the tethering of the two guanines by the sugar-
phosphate backbone plays a key role in stabilising this HH
conformation.
The same sample ((cis-1,4-DACH)Pt(d(GpG)) in D2O–CD3OD
2 : 1, v/v) was used to perform 31P NMR experiments at
diﬀerent temperatures (Fig. 4). By lowering the temperature,
the broad 31P NMR signal at ∼−2 ppm observed at 25 °C
decoalesces and, at the lowest temperature reached in the
experiment (−10 °C), splits into one sharp signal at −2.20 ppm
and a broad, weak, signal slightly more upfield. The sharp
31P NMR signal at −2.20 ppm is compatible with those
observed in water for HH1 conformers in other Pt(d(GpG))
adducts.46,47,59 The more upfield signal is consistent with
either a mixture of oligomeric Pt(d(GpG)) adducts with
unstrained backbones (expected to have signals in this region)
or with minor conformers of (cis-1,4-DACH)Pt(d(GpG)).
Fig. 3 Selected region of the 2D NOESY (600 MHz) spectrum obtained
for (cis-1,4-DACH)Pt(d(GpG)) in D2O–CD3OD (2 : 1, v/v) at −10 °C.
Table 1 1H NMR shifts (ppm) for the G residues in the HH1 conformer of (cis-1,4-DACH)Pt(oligo) adducts
5′-G 3′-G
Adduct H8 H1′ H2′ H2″ H3′ H4′ H5′ H5″ H8 H1′ H2′ H2″ H3′ H4′ H5′ H5″
d(GpG)a 8.46 6.08 2.45 2.78 5.00 4.08 — — 8.94 6.26 2.45 2.57 4.64 4.16 — —
d(GGTTT)b 8.47 6.19 2.45 2.77 5.00 4.13 — — 8.90 6.08 — — — — — —
d(TGGT)c 8.29 6.29 2.48 2.88 5.38 4.33 4.08 4.12 9.24 6.30 2.78 2.48 5.37 4.53 4.25 4.08
a In D2O–CD3OD (2 : 1, v/v) at −10 °C. b In D2O–CD3OD (9 : 1, v/v) at −5 °C. c In D2O at 5 °C.
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In order to assign the 13C NMR signals of the postulated
(cis-1,4-DACH)Pt(d(GpG)) HH1 conformer, a [1H, 13C] HSQC
experiment was performed at −10 °C. The observed 3′- and
5′-G C8 signals were almost coincident (139.1 and 138.7 ppm,
respectively; Table 2). Very similar chemical shifts were also
found for the C1′ and C3′ atoms belonging to the two residues,
whereas the largest diﬀerences between the 3′-G and 5′-G resi-
dues were observed for the C2′ (Δδ = 2.0 ppm) and C4′ (Δδ =
1.1 ppm) atoms. Similar diﬀerences have been observed for
the HH1 conformer in retro-model studies of d(GpG)
adducts.46 The broad 1H/13C cross-peaks at 3.35/47.5 and 1.85/
22.5 ppm in the [1H,13C] HSQC spectrum can be assigned to
the two methynic and eight methylenic protons of cis-1,4-
DACH, respectively.
Correlation between high and low temperature H8 signals.
The two major, rather sharp H8 signals observed at 55 °C (8.18
and 8.41 ppm) must be coalescence signals of 5′-G and 3′-G H8
residues of diﬀerent conformers. How can these high tempera-
ture signals be correlated to the low temperature signals at
8.46 and 8.94 ppm (−10 °C, Fig. 2), which have been assigned,
respectively, to 5′-G H8 and 3′-G H8 of a major HH1 confor-
mer? In the fortunate case of the ((S,R,R,S)-Bip)Pt(oligo)
adducts,46,47,59 it was possible to observe initially (kinetically
controlled composition) two abundant conformers in ca. 1 : 1
ratio, while over time one of the two decreased in concen-
tration (to nearly zero) in favour of the other, which was the
most stable (equilibrium composition). The initial two confor-
mers of ((S,R,R,S)-Bip)Pt(oligo) were determined to be HH1
(dominant and increasing) and ΔHT1 (decreasing). In other
cases, the ΔHT1 conformer is long-lived enough to be
studied.58,59 The ΔHT1 conformer almost invariably has two
closely spaced, relatively upfield H8 signals at ∼7.8 ppm. The
favoured HH1 conformer is always characterized as having
widely spaced, downfield-shifted H8 signals with more variable
shifts than those for the ΔHT1 conformer.
Guided by the results of past studies, we can explain the
temperature dependence for the H8 signals (Fig. 2). We begin
by estimating the time-averaged H8 shifts for a 1 : 1 compo-
sition of HH1 and ΔHT1 conformers undergoing fast inter-
conversion. For the HH1 shifts we use the values measured
for (cis-1,4-DACH)Pt(d(GpG)) at −10 °C (8.94 and 8.46 ppm,
Fig. 2), where this conformer dominates. For the ΔHT1 confor-
mer (which is related to the HH1 conformer by having a syn
conformation of the 3′-G residue having the base flipped with
respect to the 5′-G residue), we use the chemical shifts
observed for (S,R,R,S-Bip)Pt(d(GpG)) (7.91 and 7.77 ppm for
3′-G and 5′-G, respectively).59 This leads to estimated high temp-
erature H8 shift values for (cis-1,4-DACH)Pt(d(GpG)) of 8.42
and 8.12 ppm for 3′-G and 5′-G, respectively. These two values
are very close (average discrepancy of only 0.04 ppm) to the
shifts observed at 55 °C (8.41 and 8.18 ppm). Such an agree-
ment is surprisingly good, in light of the very diﬀerent nature
of the carrier ligand and the diﬀerent solvent system. However,
we want to point out that similar chemical shifts for the ΔHT1
conformer have been observed in adducts with completely
diﬀerent carrier ligands (such as in (N,N′-Me2-piperazine)Pt-
(d(GpG))) for which the H8 chemical shifts were 7.90 and
7.78 ppm for 3′-G and 5′-G, respectively.60 Moreover, the
chemical shifts are expected to be very little aﬀected by the
composition of the solvent in the case of a water and methanol
mixture. Therefore, we can be confident that the high tempera-
ture spectrum reflects the coalescence set of signals of two
dominating conformers, HH1 and ΔHT1 (and possibly some
minor conformers). We can deduce that, at high temperature,
the 3′-G can rapidly flip between the HH and HT orientations
with respect to the 5′-G.
We turn now to the eﬀect on H8 signals of lowering the
temperature from 55 °C to −10 °C (Fig. 2). The equilibrium
position will begin to favour the HH1 conformer, and the rate
of 3′-G flipping will slow. Such a process will only slightly
aﬀect the chemical shift of the 5′-G H8 signal because this
guanine is L canted in HH1, and the H8 is already in the
shielding cone of the 3′-G, as it is in the ΔHT1 conformer.
Therefore, the broadening of the 5′-G H8 signal will be mode-
rate, as observed. In contrast, the flipping of 3′-G will strongly
aﬀect the 3′-G H8 signal, which is deshielded by the L-canted
cis 5′-G base in the HH1 conformer but is shielded by the cis G
in the ΔHT1 conformer. Therefore, the resulting large changes
in H8 chemical shift with temperature will lead to more pro-
nounced broadening of 3′-G H8 signal. A similar explanation
for changes in shift has been proposed by Kozelka et al. for
the (N,N,N′-trimethylethylenediamine)Pt(d(GpG)) adduct.93
Thus, the spectral changes observed for the (cis-1,4-DACH)Pt-
(d(GpG)) adduct can be rationalized by the presence of two
dominant conformers, HH1 and ΔHT1, in rapid interconver-
Fig. 4 31P NMR (242.93 MHz) spectra of the (cis-1,4-DACH)Pt(d(GpG))
adduct in D2O–CD3OD (2 : 1, v/v) at diﬀerent temperatures.
Table 2 13C NMR shifts (ppm) for the (cis-1,4-DACH)Pt(d(GpG)) HH1
adduct in D2O–CD3OD (2 : 1, v/v) at −10 °C
G C8 C1′ C2′ C3′ C4′
5′ 138.7 82.8 38.6 71.1 85.5
3′ 139.1 83.2 40.6 71.5 86.6
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sion at high temperature and by a decrease in the rate of inter-
conversion and a change in the equilibrium composition
greatly favouring the HH1 conformer upon lowering the temp-
erature. However, a small abundance of the ΔHT1 conformer
in moderately fast exchange with the HH1 conformer cannot
be ruled out because this situation will not significantly
broaden the HH1 H8 signals, and broad, weak ΔHT1 signals
would escape detection. A small abundance of the ΔHT1 con-
former in the dynamic equilibrium would explain the non-neg-
ligible H8–H1′ NOE cross-peak observed for 3′-G in the (cis-1,4-
DACH)Pt(d(GpG)) adduct. A strong H8–H1′ NOE is observed
for 3′-G in ΔHT1 conformers because of the syn conformation
of the 3′-G residue.58–60,64,96
Theoretical calculations. Theoretical calculations were per-
formed on (cis-1,4-DACH)Pt(d(GpG)) to explore possible con-
formations in more detail. Starting from the PM6-DH2
optimised geometry of an HH1 conformation, a stochastic con-
formational search for all rotatable bonds was performed. This
procedure led to 54 conformations that, when plotted accord-
ing to their C8–N7–Pt–N7 torsion angles, clearly fall into four
distinct families of conformations corresponding to two HH
and two HT groups (Fig. 5). In total 21 HH1, 17 HH2, 9 ΔHT1
and 7 ΛHT2 conformations were located. The lowest-energy
structure located in this search corresponds to an HH2 confor-
mation with the 5′-G residue in an anti conformation and the
3′-G residue in the syn conformation, and the next two lowest
energy conformers were also classed as HH2. The first HH1
form was found 1 kcal mol−1 higher in energy than the global
minimum, the first ΛHT2 form at 1.5 kcal mol−1, and the first
ΔHT1 at 7.3 kcal mol−1. Thus, while this analysis supports the
finding that this complex is conformationally flexible, and the
speed of the LFMM method allows eﬃcient exploration of con-
formational space of such a complex, the details of specific
conformations found to have low energy do not agree with
experimental observations.
This lack of agreement with experimental data led us to
look in more detail at structures and energies, since the mole-
cular mechanics formalism used may not reflect all the subtle-
ties of conformational freedom in these systems. All 54
conformations were therefore re-optimised using the semi-
empirical PM6-DH2 method, in both gas-phase and simulated
aqueous solvent, with a Na+ ion placed in the proximity of the
phosphate group. It was found that MM and PM6-DH2 ener-
gies are almost completely unrelated (R2 = 0.007), with high
energy conformers from the former method becoming
amongst the lowest energy forms after re-optimization with the
latter. The energy of the most stable PM6-DH2 structure from
each family is reported in Table 3, and confirms that these pre-
dictions are quite diﬀerent from those of MM. In both the gas
and aqueous phases, an HH1 conformer is found to be the
most stable of all 54 conformations considered. The HH2 form
is much higher in energy, while both HT forms are lower than
HH2 but significantly less stable than the global minimum.
Thus the PM6-DH2 calculations correctly show that, after
HH1, ΔHT1 is the most preferred conformation. Correction
of the values in Table 3 for thermal and entropy eﬀects at a
range of temperatures similar to those used for NMR experi-
ments had essentially no eﬀect on the energy order.
Table 3 Relative energies of (cis-1,4-DACH)Pt(d(GpG)) adduct confor-
mations (kcal mol−1)
PM6-DH2
Gas-phase Aqueous-phase
HH1 0.0 0.0
HH2 22.8 21.6
ΛHT2 14.2 5.9
ΔHT1 8.2 5.8
Fig. 5 Scatter plot of 3’ C8–N7–Pt–N7 vs. 5’ C8–N7–Pt–N7 torsion angles found in conformational search.
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The PM6-DH2 optimised HH1 geometry has both guanines
in their anti-form, whereas the lowest energy ΔHT1 form has
5′-G in anti- and 3′-G in syn-forms; therefore a fast interconver-
sion between HH1 and ΔHT1 (even if ΔHT1 is present in
small amounts at low temperature) can explain the NMR data
showing a partial syn conformation for 3′-G.
Reaction with d(GGTTT)
The 1H NMR spectrum of free d(GGTTT) in D2O solution at pH
∼ 4 consists of two G H8 (8.03 and 7.82 ppm, assigned to 3′-G
and 5′-G, respectively) and three T H6 signals (7.68, 7.63, and
7.55 ppm). These signals dominate in the 10 min trace in
Fig. S2 (ESI†). Addition of [Pt(OD2)2(cis-1,4-DACH)]
2+ produces
new signals in the 9–7 ppm region (Fig. S2†): two broad G H8
signals (8.52 and 8.25 ppm) and two resolved T H6 peaks (7.66
and 7.63 ppm, integrating for 2 protons and 1 proton, respect-
ively). The downfield shift of the G H8 signals is consistent
with coordination of both G residues to Pt to form the (cis-1,4-
DACH)Pt(d(GGTTT)) adduct.
Temperature eﬀect. Upon raising the temperature (40 °C),
the two broad H8 signals of (cis-1,4-DACH)Pt(d(GGTTT) at
25 °C (Fig. 6) become sharper and shift slightly upfield (to 8.48
and 8.22 ppm); the diﬀerence in chemical shift (Δδ =
0.26 ppm) remains almost unchanged when compared to that
at 25 °C. Bringing the reaction mixture back to 25 °C restores
the initial spectrum with the two broad H8 signals. Upon low-
ering the temperature, the two broad H8 signals first merge
into a single, very broad feature (15 °C) and then sharpen
again, giving (at 5 °C) two clear H8 signals at 8.40 and
8.80 ppm. (A broader feature around 8.20 ppm, still present,
probably belongs to oligomeric platinum adducts.)
In order to be able to lower the temperature even further,
we added some methanol to the sample solution (D2O–CD3OD
9 : 1, v/v) and recorded the 1H NMR spectrum at −5 °C (Fig. 6),
which showed the G H8 signals shifted further downfield (to
8.47 and 8.90 ppm). In the 2D NOESY spectrum recorded at
−5 °C (Fig. 7), the two H8 signals exhibit a cross-peak indica-
tive of an HH arrangement of the G bases. The more upfield
H8 signal (8.47 ppm; Table 1) has H8–H2′/H2″ NOE cross-
peaks, while the H8–H1′ NOE cross-peak is weak; both features
are indicative of an anti nucleotide conformation. Moreover,
an H8–H3′ cross-peak is consistent with an N-sugar pucker
characteristic of a 5′-G residue.46 Thus, the more upfield H8
signal can be assigned to 5′-G. The more downfield H8 signal
at 8.90 ppm (Table 1) shows complete absence of an H8–H3′
NOE cross peak, indicative of an S-sugar pucker characteristic
of a 3′-G residue.91 Thus the downfield H8 signal must belong
to 3′-G. In this case there is quite an intense H8–H1′ cross-
peak. The presence of a H8–H1′ cross-peak indicates either a
partial syn character58–60,64,91,94 for the 3′-G of the dominant
conformer or, more likely, the existence of a minor ΔHT1 con-
former in dynamic equilibrium with the dominant HH1 con-
former. Such a dynamic equilibrium would explain the
somewhat broad nature of the H8 signals, even at −5 °C
(Fig. 6). An upfield 5′-G H8 signal is indicative of a left-hand
Fig. 6 Temperature dependence of the downﬁeld region of the 1H
NMR (400 MHz) spectrum of (cis-1,4-DACH)Pt(d(GGTTT)) in D2O solu-
tion (pH ∼ 4). The spectrum at −5 °C was recorded after addition of
methanol to the sample solution (D2O–CD3OD 9 : 1, v/v). The asterisk
indicates an impurity present in the solvent (likely formate from plastic
pipette tips).
Fig. 7 Selected region of the 2D NOESY spectrum (700 MHz) obtained
for (cis-1,4-DACH)Pt(d(GGTTT)) in D2O–CD3OD (9 : 1, v/v) at −5 °C.
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canting of the 5′-G, as expected for a cis-A2Pt(ss-oligo)
adduct.5,6,27,31,33,34,43
Free d(GGTTT) at 25 °C consists of two overlapping 31P
NMR signals at −4.17 ppm and a third signal at −4.25 ppm.
Complexation to platinum causes broadening and shift to
lower field (−3.54 ppm) of one 31P NMR signal (undoubtedly
arising from the phosphodiester group connecting the two
cross-linked G’s, Fig. S3 in the ESI† and Table 4). The value of
the 31P NMR chemical shift of the GpG signal (−3.54 ppm) lies
between the values typically found for the HH1 (∼−3 ppm) and
the ΔHT1 conformer (∼−5 ppm).17,59 Moreover, the broadness
of the GpG 31P signal indicates that there is interconversion
between conformers at a rate comparable to the NMR time
scale.
Overall, the behaviour of (cis-1,4-DACH)Pt(d(GGTTT))
appears to be very similar to that of (cis-1,4-DACH)Pt(d(GpG)),
as expected from our retro-modelling studies on short oligos
diﬀering only in the presence of additional residues in the 3′
position.46,47 In both d(GpG) and d(GGTTT) adducts, the
absence of additional residues in the 5′ position is consistent
with our previous finding that other conformers in addition to
HH1 are possible.47,59 In the cases in which the adducts are
not dynamic, we have established that the next most favoured
conformer is ΔHT1.58 This interpretation of a rapidly inter-
converting HH1/ΔHT1 conformer mixture, with ΔHT1 becoming
less abundant at lower temperature, explains the temperature
dependence of the G H8 signals between 5 °C and 40 °C, as
discussed above for the (cis-1,4-DACH)Pt(d(GpG)) adduct. The
syn conformation of the 3′-G residue of the ΔHT1 conformer is
well documented;46,58 a small amount of the ΔHT1 conformer
can explain the observation of a significant H8–H1′ cross-peak
in the 2D NOESY spectrum at −5 °C (Fig. 7).
Reaction with d(TGGT)
The progress of the reaction between [Pt(OD2)2(cis-1,4-
DACH)]2+ and d(TGGT) (room temperature, pH ∼ 4) was moni-
tored by 1H NMR spectroscopy (Fig. S4 in the ESI†). Initially,
the 1H NMR spectrum (5–10 ppm region) showed only the
signals of free d(TGGT) (singlets at 8.00, 7.90, 7.54, and
7.43 ppm assigned to 3′-G H8, 5′-G H8, 3′-T H6, and 5′-T H6,
respectively; and doublets of doublets falling at 6.23, 6.13,
6.06, and 5.89 ppm assigned to H1′ protons of 3′-T, 3′-G, 5′-G,
and 5′-T, respectively. The numbering scheme of d(TGGT) is
shown in Fig. S5 of the ESI†).33,46,47 After 1 day, a new set of
signals was observed in the aromatic region; after 26 days this
new set became exclusive, indicating that the reaction had
reached completion. The downfield shift of the G H8 signals
in the new set of signals indicates formation of a (cis-1,4-
DACH)Pt(d(TGGT)) adduct, in which the Pt atom is co-
ordinated to the adjacent G residues. As for the H8 signals of
the G residues, the H6 signals of the T residues and the H1′
signals were also shifted to lower field. Importantly, unlike our
findings for (cis-1,4-DACH)Pt(d(GpG)) and (cis-1,4-DACH)Pt-
(d(GGTTT)), the H8 signals of the (cis-1,4-DACH)Pt(d(TGGT))
adduct show little broadening.
The complete assignment of the signals for the non-
exchangeable base and sugar protons of the two G’s in the (cis-
1,4-DACH)Pt(d(TGGT)) adduct was accomplished through 2D
COSY and NOESY spectra (Table 1). In particular, the 2D
NOESY spectrum recorded at 5 °C (Fig. 8) showed a NOE cross-
peak between the two sharp H8 signals, which is indicative of
an HH conformer. The more upfield H8 signal (8.29 ppm,
Table 1) showed H8–H2′/H2″ cross-peaks but no detectable
H8–H1′ NOE cross-peak; both features are characteristic of an
anti conformation.91,95,96 Moreover, a strong H8–H3′ cross-
peak is consistent with an N sugar pucker,26,31,91 characteristic
of a 5′-G residue in an intrastrand cross-link.5,8,17,58–60,64 The
more downfield H8 signal (9.24 ppm; Table 1) showed strong
H8–H2′/H2″ cross-peaks and a nearly undetectable H8–H1′
cross-peak, which are indicative of an anti residue.91,95,96 More-
over, the complete absence of an H8–H3′ cross-peak suggests
that the sugar of this residue retains the S pucker;91 therefore,
these signals are assigned to the 3′-G residue because the S
pucker is characteristic of the 3′-G residue. As found for (cis-
1,4-DACH)Pt(d(GpG)) and (cis-1,4-DACH)Pt(d(GGTTT)), the
(cis-1,4-DACH)Pt(d(TGGT)) adduct also has an upfield 5′-G H8
signal indicative of L canting of the 5′-G, a common feature of
cis-A2Pt(ss-oligo) adducts.
The 31P NMR spectrum of (cis-1,4-DACH)Pt(d(TGGT)), taken
at 25 °C, consists of three signals at −2.95, −4.09, and
Fig. 8 Selected region of the 2D NOESY (600 MHz) spectrum obtained
for (cis-1,4-DACH)Pt(d(TGGT)) in D2O at 5 °C.
Table 4 31P NMR shifts (ppm) for free d(GGTTT) and (cis-1,4-DACH)Pt-
(d(GGTTT)) at 25 °C
GpG GpT TpTpT
d(GGTTT) −4.17 −4.17 −4.25
(cis-1,4-DACH)Pt(d(GGTTT)) −3.54 −4.18 −4.29
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−4.17 ppm (Fig. S6 in the ESI†). The 31P NMR chemical shifts
for free and complexed d(TGGT) are listed in Table 5; the large
downfield change in chemical shift of the GpG phosphodiester
group (from −4.14 ppm in free d(TGGT) to −2.95 ppm in the
(cis-1,4-DACH)Pt(d(TGGT)) adduct) confirms that the adduct
exists mostly in the HH1 conformation.17,31,60,64
Temperature eﬀect. The eﬀect of temperature on the 1H
(Fig. 9) and 31P NMR spectra (Fig. S7 in the ESI†) of (cis-1,4-
DACH)Pt(d(TGGT)) (D2O solution) was also investigated. At
25 °C the 3′-G H8 signal (9.06 ppm) is broad and 0.86 ppm
downfield with respect to the 5′-G H8 signal (8.20 ppm).
Raising the temperature caused the 3′-G H8 signal of (cis-
1,4-DACH)Pt(d(TGGT)) to shift upfield (from 9.06 ppm at
25 °C to 9.00 ppm at 40 °C), while the 5′-G H8 signal shifted
downfield (from 8.20 ppm at 25 °C to 8.22 ppm at 40 °C), and
the separation between the two resonances decreased from
0.86 (25 °C) to 0.78 ppm (40 °C) (Fig. 9; Table S1 in the ESI†).
Moreover, both the 3′-G and 5′-G H8 signals became sharper.
Lowering the temperature to 5 °C resulted in further
deshielding of the 3′-G H8 signal (9.15 ppm), which became
sharper and was farther (0.98 ppm) from the 5′-G H8 signal
(8.17 ppm). The separation between the two H8 resonances
was larger at 5 °C than at 25 °C (Fig. 9, Table S1†). These data
suggest that in solution a major conformer (probably the HH1
conformer) is in equilibrium with another conformer (prob-
ably the ΔHT1 conformer) whose concentration (unlike the
d(GpG) and the d(GGTTT) cases) always remains low, as
judged by the small shift and change of peak sharpness with
the temperature (estimated ∼5% ΔHT1). In retro-model
studies, the minor ΔHT1 conformer has been shown to have a
low abundance when there is a residue on the 5′-G.46,47 At 5 °C
the interconversion between the two conformers is slower than
at 25 °C, which could explain both the sharpening of the
downfield H8 signal of the dominating conformer and the
increased separation between the two H8 signals. Therefore,
because the downfield signal of the dominating conformer
has its counterpart resonance (in the low-percent ΔHT1 con-
former) falling at much higher field, a lowering of the inter-
conversion rate between conformers will have a greater eﬀect
(both in terms of sharpness and chemical shift) on the down-
field signal than on the upfield signal, for which the chemical
shift is close to that of its counterpart in the low-percent con-
former. The low abundance of the ΔHT1 conformer and its
slow exchange with the major HH1 conformer are also consist-
ent with the very weak H8–H1′ NOE cross-peak observed for
the 3′-G residue, which has the anti conformation in the domi-
nant HH1 conformer.
The 5′-G H1′ signal of (cis-1,4-DACH)Pt(d(TGGT)) was also
aﬀected by temperature (Fig. S8 in the ESI†). At 25 °C this
signal overlapped with other H1′ signals (see also Fig. 9).
When the temperature was raised from 25 to 40 °C, the 5′-G
H1′ signal shifted downfield (Fig. S8), and the 40 °C spectrum
showed the signal as a doublet ( J1′–2′ < 0.5 Hz and J1′–2″ = 7.17
Hz), confirming an N-type ribose conformation. However, at
lower temperatures the 5′-G H1′ signal shifted upfield and
broadened to such an extent that below 15 °C it was lost in the
base line. The other H1′ signals, in contrast, underwent little
shift. This unusual behaviour has been observed with other
adducts,33 and thus we conclude that the sugar-phosphate
backbone in (cis-1,4-DACH)Pt(d(TGGT)) is representative of the
backbone in other adducts.
The TGpGT 31P signal was not strongly aﬀected by tempera-
ture; however, increasing the temperature from 5 to 40 °C
shifted the TGpGT 31P signal from −3.03 to −2.87 ppm
(Fig. S7, Table S2†). These values also indicate that the back-
bone is similar to that in other adducts.33
Compared to (cis-1,4-DACH)Pt(d(GpG)) and (cis-1,4-DACH)-
Pt(d(GGTTT)) adducts, the presence of a 5′ residue flanking
the coordinated 5′-G in (cis-1,4-DACH)Pt(d(TGGT)) is respon-
sible for the small abundance of the HT conformer found even
at high temperature and, as a consequence, the small changes
of H8 chemical shifts as a function of temperature. This 5′-sub-
stituent eﬀect favouring the HH1 conformer is well documen-
ted.46,47,61 This finding is further evidence that (cis-1,4-DACH)-
Pt(d(TGGT)) is representative of many d(TGGT) adducts with
several other carrier ligands used in retro-modelling studies.
Although as extensive a study of temperature eﬀects was not
conducted for the d(TGGT) adduct derived from cisplatin, this
latter adduct has H8 signals at 9.04 ppm (3′-G) and 8.25 ppm
Table 5 31P NMR shifts (ppm) for d(TGGT) and (cis-1,4-DACH)Pt-
(d(TGGT)) at 25 °C
GpG GpT TpG
d(TGGT) −4.14 −4.20 −4.09
(cis-1,4-DACH)Pt(d(TGGT)) −2.95 −4.09 −4.17
Fig. 9 Temperature dependence of the downﬁeld portion of the 1H
NMR (400 MHz) spectrum of (cis-1,4-DACH)Pt(d(TGGT)) in D2O (pH ∼
4). The asterisk indicates an impurity of the sample (likely formate from
plastic pipette tips).
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(5′-G) at 22 °C and a 31P NMR signal at −3.02 ppm at 15 °C.33
It is noteworthy that these values are almost identical to those
found here [9.06 ppm (3′-G H8), 8.20 ppm (5′-G H8) and GpG
31P NMR signal at −2.95 ppm at 25 °C] for the (cis-1,4-DACH)-
Pt(d(TGGT)) adduct. For both the cisplatin and the Kiteplatin
adducts, the GpG 31P NMR signal shifts slightly upfield with
temperature.
Conclusions
In the present work the behaviour of (cis-1,4-DACH)Pt(d(GpG)),
(cis-1,4-DACH)Pt(d(GGTTT)), and (cis-1,4-DACH)Pt(d(TGGT))
adducts has been investigated by 1H and 31P NMR spec-
troscopy and compared to that of related cross-link adducts of
these same short DNA fragments but with more bulky and less
bulky carrier ligands. From this direct comparison of adducts,
we conclude that the carrier ligand present in Kiteplatin, cis-
1,4-DACH, influences the dynamic properties much more than
the less bulky carrier ligands but much less than more bulky
carrier ligands. The new results indicate that bulk is much less
important in influencing the equilibrium or structural pro-
perties of adducts.
The shifts of the 1H and 31P NMR signals reflect values
found with highly dynamic adducts having less bulky carrier
ligands associated with anticancer activity. At 25 °C and at
somewhat elevated temperatures, NMR signals are broad,
unlike the sharp signals observed for adducts with cisplatin or
with other primary amines. We conclude that the very large
bite angle of cis-1,4-DACH, coupled with the rigid frame of the
chelating cyclohexane ring inserted in the 7-member chelate,
slows down the interconversion between diﬀerent conformers
in (cis-1,4-DACH)Pt(ss-oligo) cross-linked adducts. Thus, the
cis-1,4-DACH ligand is a very valuable and informative carrier
ligand because it has allowed us to detect evidence for the
coexistence of diﬀerent conformers in a system containing a
primary diamine carrier ligand associated with anticancer
activity. Furthermore, the results from adducts with the cis-1,4-
DACH ligand, which is relatively non-bulky, confirm the pre-
vious hypothesis that the coexistence of diﬀerent conformers
established in studies of retro models that have relatively bulky
ligands is not an artefact resulting from carrier-ligand bulk.94
At close to the physiological temperature (40 °C), the 1H
and 31P NMR data for the (cis-1,4-DACH)Pt(d(GpG)) and (cis-
1,4-DACH)Pt(d(GGTTT)) adducts indicate a mixture of compar-
able amounts of mostly HH1 and ΔHT1 conformers. In con-
trast, the data for the (cis-1,4-DACH)Pt(d(TGGT)) adduct
indicate that, even at high temperature, there is one major,
highly dominant conformer (HH1), and any ΔHT1 conformer
present has a very small concentration, thus causing only a
minimal broadening of the H8 NMR signals. This result is
fully consistent with findings for adducts with many diﬀerent
bulky carrier ligands, in which the eﬀect of 5′-substituents on
the 5′-G of the cross-link is to favour the normal HH1
conformer.
At low temperature (close to 0 °C), our results are unique
because they show that for the (cis-1,4-DACH)Pt(d(GpG)) and
(cis-1,4-DACH)Pt(d(GGTTT) adducts, the equilibrium between
HH1 and ΔHT1 conformers (present in comparable amounts
at 40 °C) shifts dramatically toward the more stable HH1 con-
former. (A very small shift was observed for the (cis-1,4-DACH)-
Pt(d(TGGT)) adduct for which the HH1 conformer was already
dominant at high temperature.)
Conformational searching using ligand field molecular
mechanics (LFMM), performed on the d(GpG) adduct, located
four families of conformations, the lowest energy of which cor-
responded to an HH2 conformer with syn and anti confor-
mations for 3′-G and 5′-G residues, respectively. In contrast,
semi-empirical PM6-DH2 studies predicted the HH1 confor-
mer to be lowest in energy in the gas phase as well as in
aqueous solution. The PM6-DH2 calculations also correctly
show that, after HH1, ΔHT1 is the most preferred confor-
mation. Furthermore, the calculations confirmed that the 3′-G
residue has anti conformation in HH1 while it has syn confor-
mation in ΔHT1; therefore, a rapid interconversion between
HH1 and ΔHT1 (even if ΔHT1 is present in small amounts at
low temperature) can explain the NMR data showing a partial
syn conformation for 3′-G.
Because the bulk of the cis-1,4-DACH carrier ligand does
not have a dramatic eﬀect on conformer stability or structure,
the main local eﬀect of the ligand, namely the impeded
rotation of the guanine bases with respect to the Pt–N7 bond,
could contribute to the markedly diﬀerent biological activity of
kiteplatin69–71 as compared to those of cisplatin and
oxaliplatin.69–71,79 Alternatively, and perhaps more likely, the
shape and bulk of the carrier ligand, as it projects out away
from the DNA helix, will influence interactions with nucleic
acid binding proteins or repair enzymes, thereby influencing
activity.
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